Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome: Impact on Metabolic and Reproductive Abnormalities

Author： Elkind-Hirsch Karen E.

Publisher： Adis International

ISSN： 1175-6349

Source： Treatments in Endocrinology, Vol.5, Iss.3, 2006-01, pp. : 171-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects

By Nardo L. G. Rai R.

Gynecological Endocrinology, Vol. 15, Iss. 5, 2001-10 ,pp. : 373-380

Informa Healthcare

Access to resources Recommend Favorite

Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome

By Fruzzetti Franca Perini Daria Lazzarini Veronica Parrini Donatella Genazzani Andrea

Gynecological Endocrinology, Vol. 25, Iss. 5, 2009-05 ,pp. : 335-343

Informa Healthcare

Access to resources Recommend Favorite

Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping

By Caserta Donatella Adducchio Gloria Picchia Simona Ralli Eleonora Matteucci Eleonora Moscarini Massimo

Gynecological Endocrinology, Vol. 30, Iss. 6, 2014-06 ,pp. : 397-402

Informa Healthcare

Access to resources Recommend Favorite

Metabolic syndrome in adolescents with polycystic ovary syndrome

By VrbÍková Jana Zamrazilová Hana SedláČČková Barbora Šnajderová Marta

Gynecological Endocrinology, Vol. 27, Iss. 10, 2011-10 ,pp. : 820-822

Informa Healthcare

Access to resources Recommend Favorite

Current management of polycystic ovary syndrome

By Choudhary Meenakshi

Human Fertility, Vol. 14, Iss. 3, 2011-09 ,pp. : 201-201

Informa Healthcare

Access to resources Recommend Favorite